[go: up one dir, main page]

WO2008120766A1 - Composition analgésique - Google Patents

Composition analgésique Download PDF

Info

Publication number
WO2008120766A1
WO2008120766A1 PCT/JP2008/056240 JP2008056240W WO2008120766A1 WO 2008120766 A1 WO2008120766 A1 WO 2008120766A1 JP 2008056240 W JP2008056240 W JP 2008056240W WO 2008120766 A1 WO2008120766 A1 WO 2008120766A1
Authority
WO
WIPO (PCT)
Prior art keywords
analgesic
analgesic composition
composition
agent
compared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/056240
Other languages
English (en)
Japanese (ja)
Inventor
Manabu Nozaki
Shigeki Sawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of WO2008120766A1 publication Critical patent/WO2008120766A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention vise à proposer une composition analgésique qui est plus sûre par comparaison avec un agent analgésique classique et présente une activité analgésique au même niveau ou à un niveau supérieur par comparaison avec un agent analgésique classique. A cet effet, l'invention concerne une composition analgésique comprenant de la vitamine B12 en tant que principe actif. De préférence, la composition analgésique contient en outre de l'acide folique.
PCT/JP2008/056240 2007-03-30 2008-03-28 Composition analgésique Ceased WO2008120766A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-091794 2007-03-30
JP2007091794A JP5241127B2 (ja) 2007-03-30 2007-03-30 鎮痛用組成物

Publications (1)

Publication Number Publication Date
WO2008120766A1 true WO2008120766A1 (fr) 2008-10-09

Family

ID=39808346

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/056240 Ceased WO2008120766A1 (fr) 2007-03-30 2008-03-28 Composition analgésique

Country Status (2)

Country Link
JP (1) JP5241127B2 (fr)
WO (1) WO2008120766A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7026457B2 (ja) * 2016-07-07 2022-02-28 第一三共ヘルスケア株式会社 ロキソプロフェン又はその塩及びビタミンｂ１２類を含有する経口用医薬組成物
JP7499027B2 (ja) * 2019-12-27 2024-06-13 小林製薬株式会社 内服用医薬組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050028A1 (fr) * 1999-02-24 2000-08-31 Andrew Peter Worsley Compositions pour le traitement de la douleur
WO2000056404A1 (fr) * 1999-03-24 2000-09-28 Kilgowan Limited Formulations pour le traitement de la douleur contenant de la vitamine b12 et de la phenylanine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050028A1 (fr) * 1999-02-24 2000-08-31 Andrew Peter Worsley Compositions pour le traitement de la douleur
WO2000056404A1 (fr) * 1999-03-24 2000-09-28 Kilgowan Limited Formulations pour le traitement de la douleur contenant de la vitamine b12 et de la phenylanine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BRUGGEMANN G. ET AL.: "Results of a double-blind study of diclofenac + vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae", KLIN. WOCHENSCHR., vol. 68, no. 2, 1990, pages 116 - 120 *
GLUECK C.J. ET AL.: "Stromelysin-1 5A/6A and eNOS T-768C polymorphisms, MTHFR C677T and A1298C mutations, and cigarette-cannabis smoking: a pilot, hypothesis-generating study of gene-environment pathophysiological associations with Buerger's disease", CLIN. APPL. THROMB. HEMOST., vol. 12, no. 4, 2006, pages 427 - 439 *
O'SHAUGHNESSY J.A. ET AL.: "Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer", CLIN. BREAST CANCER, vol. 6, no. 2, 2005, pages 143 - 149 *

Also Published As

Publication number Publication date
JP5241127B2 (ja) 2013-07-17
JP2008247823A (ja) 2008-10-16

Similar Documents

Publication Publication Date Title
WO2012019426A8 (fr) Dérivé de phtalazinone, son procédé de préparation et utilisation pharmaceutique
WO2007086001A3 (fr) Nouveaux dérivés de pyridine
WO2009089494A3 (fr) Compositions pharmaceutiques
WO2012019430A8 (fr) Dérivé de phtalazinone, son procédé de préparation et utilisation pharmaceutique
WO2010030598A3 (fr) Formulations pharmaceutiques comprenant du pemetrexed
MX2010004576A (es) Derivados de pirimidina novedosos.
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
WO2012019427A8 (fr) Dérivé de phtalazinone cétone, son procédé de préparation et utilisation pharmaceutique
WO2007127158A3 (fr) Modification d'absorption percutanée de matériaux topiquement actifs
MY154909A (en) Novel thiophene derivatives
WO2008070268A3 (fr) Compositions pharmaceutiques
WO2011012816A3 (fr) Formulation pharmaceutique
WO2009062746A3 (fr) Médicaments topiques pour le traitement antimycotique
WO2008148074A3 (fr) Inhibiteurs de mtor et methodes de traitement mettant en œuvre ces inhibiteurs
WO2009078447A1 (fr) Agent contre les norovirus, agent contre le virus de la grippe et procédé de traitement antiviral utilisant chacun de ces agents
WO2008017346A3 (fr) Utilisation de dérivés d'acide ascorbique pour la fonctionnalisation de matrices
WO2010021607A3 (fr) Préparation pharmaceutique
TW200942530A (en) Pyridine compounds
WO2011126250A3 (fr) Composition contenant un inhibiteur de pde5 pour l'atténuation des rides de la peau
WO2009135593A3 (fr) Formulation pharmaceutique solide à libération retardée
WO2011049327A3 (fr) Composition de soin externe pour la peau comprenant un sel et du sucre en tant que principes actifs pour prévenir et traiter la vaginose et utilisation de cette composition
WO2009041663A1 (fr) Agent destiné à la prévention et/ou au traitement de maladies cutanées
EP2316420A8 (fr) Procédé pour réduire la douleur
WO2011076209A3 (fr) Composition pharmaceutique comprenant un mélange de solvants et un dérivé de la vitamine d ou analogue
WO2009038095A1 (fr) Composition comprenant de la sésamine et de la vitamine b1

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08739358

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08739358

Country of ref document: EP

Kind code of ref document: A1